CRISPR, Gene Therapies, and Cure Pricing Conundrums
Motley Fool Money
Insights into Biotech Ownership and CRISPR Therapeutics Challenges
This chapter examines the role of insider ownership in biotech firms, with a focus on CRISPR Therapeutics and the impact of low insider stakes on investor confidence. It also addresses the challenges of funding and gene editing in developing effective cancer therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
